Articles:

Pharmacogenetics in cancer etiology and chemotherapy

AV Boddy and MJ Ratain
Clin Cancer Res 1997 3: 1025 [PDF]  

Long-lasting complete inhibition of human solid tumors in SCID mice by targeting endothelial cells of tumor vasculature with antihuman endoglin immunotoxin

BK Seon, F Matsuno, Y Haruta, M Kondo, and M Barcos
Clin Cancer Res 1997 3: 1031 [Abstract] [PDF]  

Loss of KAI1 messenger RNA expression in both high-grade and invasive human bladder cancers

Y Yu, JL Yang, B Markovic, P Jackson, G Yardley, J Barrett, and PJ Russell
Clin Cancer Res 1997 3: 1045 [Abstract] [PDF]  

Prognostic significance of cyclin D1 and retinoblastoma expression in combination with p53 abnormalities in primary, resected non-small cell lung cancers

M Nishio, T Koshikawa, Y Yatabe, T Kuroishi, M Suyama, M Nagatake, T Sugiura, Y Ariyoshi, T Mitsudomi, and T Takahashi
Clin Cancer Res 1997 3: 1051 [Abstract] [PDF]  

Analysis of transforming growth factor (TGF)-alpha/epidermal growth factor receptor, hepatocyte growth Factor/c-met,TGF-beta receptor type II, and p53 expression in human hepatocellular carcinomas

A Kiss, NJ Wang, JP Xie, and SS Thorgeirsson
Clin Cancer Res 1997 3: 1059 [Abstract] [PDF]  

Changes in DNA copy number in primary gastric carcinomas by comparative genomic hybridization

Y Koizumi, Si Tanaka, R Mou, H Koganei, A Kokawa, R Kitamura, H Yamauchi, K Ookubo, T Saito, S Tominaga, K Matsumura, H Shimada, N Tsuchida, and H Sekihara
Clin Cancer Res 1997 3: 1067 [Abstract] [PDF]  

Phase IB clinical trial of the oligosaccharide processing inhibitor swainsonine in patients with advanced malignancies

PE Goss, CL Reid, D Bailey, and JW Dennis
Clin Cancer Res 1997 3: 1077 [Abstract] [PDF]  

Limited sampling model for the area under the concentration versus time curve of irinotecan and its application to a multicentric phase II trial

N Yamamoto, T Tamura, Y Nishiwaki, Y Kurita, Y Kawakami, S Abe, T Nakabayashi, S Suzuki, T Matsuda, I Hayashi, T Takahashi, and N Saijo
Clin Cancer Res 1997 3: 1087 [Abstract] [PDF]  

Phase I trial of temozolomide (NSC 362856) in patients with advanced cancer

M Dhodapkar, J Rubin, JM Reid, PA Burch, HC Pitot, JC Buckner, MM Ames, and VJ Suman
Clin Cancer Res 1997 3: 1093 [Abstract] [PDF]  

Endocrine and clinical effects of exemestane (PNU 155971), a novel steroidal aromatase inhibitor, in postmenopausal breast cancer patients: a phase I study

DC Johannessen, T Engan, E Di Salle, MG Zurlo, J Paolini, G Ornati, G Piscitelli, S Kvinnsland, and PE Lonning
Clin Cancer Res 1997 3: 1101 [Abstract] [PDF]  

A phase I study of high-dose tamoxifen for the treatment of refractory malignant gliomas of childhood

IF Pollack, RC DaRosso, PL Robertson, RL Jakacki, JR Mirro, Jr, J Blatt, S Nicholson, RJ Packer, JC Allen, A Cisneros, and VC Jordan
Clin Cancer Res 1997 3: 1109 [Abstract] [PDF]  

A phase I trial of paclitaxel plus carboplatin in untreated patients with advanced non-small cell lung cancer

K Kelly, Z Pan, J Murphy, DH Huffman, and PA Bunn, Jr
Clin Cancer Res 1997 3: 1117 [Abstract] [PDF]  

A pilot study of gamma-1b-interferon in combination with fluorouracil, leucovorin, and alpha-2a-interferon

JL Grem, N McAtee, RF Murphy, FM Balis, E Cullen, AP Chen, JM Hamilton, SM Steinberg, M Quinn, JM Sorensen, SG Arbuck, D Lawrence, J Pang, and CJ Allegra
Clin Cancer Res 1997 3: 1125 [Abstract] [PDF]  

Virus potentiation of tumor vaccine T-cell stimulatory capacity requires cell surface binding but not infection

V Schirrmacher, C Haas, R Bonifer, and C Ertel
Clin Cancer Res 1997 3: 1135 [Abstract] [PDF]  

Radiosensitization of human tumor cells by the phosphatidylinositol3-kinase inhibitors wortmannin and LY294002 correlates with inhibition of DNA-dependent protein kinase and prolonged G2-M delay

KE Rosenzweig, MB Youmell, ST Palayoor, and BD Price
Clin Cancer Res 1997 3: 1149 [Abstract] [PDF]  

Pharmacological basis for a novel therapeutic strategy based on the use of aquated cisplatin

H Zheng, D Fink, and SB Howell
Clin Cancer Res 1997 3: 1157 [Abstract] [PDF]  

Inhibition of platelet-derived growth factor-mediated signal transduction and tumor growth by N-[4-(trifluoromethyl)-phenyl]5-methylisoxazole-4-carboxamide

LK Shawver, DP Schwartz, E Mann, H Chen, J Tsai, L Chu, L Taylorson, M Longhi, S Meredith, L Germain, JS Jacobs, C Tang, A Ullrich, ME Berens, E Hersh, G McMahon, KP Hirth, and TJ Powell
Clin Cancer Res 1997 3: 1167 [Abstract] [PDF]  

Antitumor activity of a C-raf antisense oligonucleotide in combination with standard chemotherapeutic agents against various human tumors transplanted subcutaneously into nude mice

T Geiger, M Muller, BP Monia, and D Fabbro
Clin Cancer Res 1997 3: 1179 [Abstract] [PDF]  

Adenoviral-mediated delivery of gastrin-releasing peptide receptor results in specific tumor localization of a bombesin analogue in vivo

ME Rosenfeld, BE Rogers, MB Khazaeli, G Mikheeva, D Raben, MS Mayo, DT Curiel, and DJ Buchsbaum
Clin Cancer Res 1997 3: 1187 [Abstract] [PDF]  

The utility of p53 immunostaining of transbronchial biopsy specimens of lung cancer: p53 overexpression predicts poor prognosis and chemoresistance in advanced non-small cell lung cancer

M Kawasaki, Y Nakanishi, K Kuwano, J Yatsunami, K Takayama, and N Hara
Clin Cancer Res 1997 3: 1195 [Abstract] [PDF]  

Expression of the prostate specific antigen gene by lung tissue

N Zarghami, M D'Costa, D Tsuyuki, SL Asa, and EP Diamandis
Clin Cancer Res 1997 3: 1201 [Abstract] [PDF]  

Comparison of oncogene mutation detection and telomerase activity for the molecular staging of non-small cell lung cancer

SA Ahrendt, SC Yang, L Wu, WH Westra, J Jen, JA Califano, and D Sidransky
Clin Cancer Res 1997 3: 1207 [Abstract] [PDF]  

Combined nested reverse transcription-PCR assay for prostate-specific antigen and prostate-specific membrane antigen in detecting circulating prostatic cells

Y Zhang, CD Zippe, F Van Lente, EA Klein, and MK Gupta
Clin Cancer Res 1997 3: 1215 [Abstract] [PDF]  

Clinical investigation of neuroblastoma with partial deletion in the short arm of chromosome 1

K Ohtsu, E Hiyama, T Ichikawa, Y Matsuura, and T Yokoyama
Clin Cancer Res 1997 3: 1221 [Abstract] [PDF]  

Microsatellite alterations at 5q21, 11p13, and 11p15.5 do not predict survival in non-small cell lung cancer

M Sanchez-Cespedes, R Rosell, A Pifarre, MP Lopez-Cabrerizo, A Barnadas, JJ Sanchez, JC Lorenzo, A Abad, M Monzo, and JJ Navas-Palacios
Clin Cancer Res 1997 3: 1229 [Abstract] [PDF]  

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.